相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study
Albert Abad et al.
ACTA ONCOLOGICA (2008)
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
M. Bouchahda et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help - A SIOG surgical task force prospective study
R. A. Audisio et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer:: Combined analysis of 2,691 patients in randomized controlled trials
Gunnar Folprecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Short-course preoperative radiotherapy with delayed surgery in rectal cancer - A retrospective study
Catin Radu et al.
RADIOTHERAPY AND ONCOLOGY (2008)
First-line single-agent cetuximab in patients with advanced colorectal cancer
A. Pessino et al.
ANNALS OF ONCOLOGY (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I study of AZD0530, an oral potent inhibitor of Src kinase: First demonstration of inhibition of Src activity in human cancers
J. Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant therapy in the elderly: Making the right decision
Hyman B. Muss et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Managing older patients with colorectal cancer
Hanna Kelly Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term outcome after operative intervention for rectal cancer in patients aged over 80 years: Analysis of 9,501 patients
Ravi Pokala Kiran et al.
DISEASES OF THE COLON & RECTUM (2007)
The illness trajectory of elderly cancer patients across cultures: SIOG position paper
A. Surbone et al.
ANNALS OF ONCOLOGY (2007)
Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia
Jaroslaw Regula et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Outcomes after major hepatectomy in elderly patients
Krishna V. Menon et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
K. Bujko et al.
BRITISH JOURNAL OF SURGERY (2006)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2006)
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer
Richard M. Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population
S. Manfredi et al.
BRITISH JOURNAL OF SURGERY (2006)
Prediction of postoperative mortality in elderly patients with colorectal cancer
Alexander G. Heriot et al.
DISEASES OF THE COLON & RECTUM (2006)
Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care
Siran M. Koroukian et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly
Alfred I. Neugut et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
JN Vauthey et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-06
BC Lembersky et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
G Folprecht et al.
ANNALS OF ONCOLOGY (2006)
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
M Karoui et al.
ANNALS OF SURGERY (2006)
Adjuvant chemotherapy for stage III colon cancer - Implications of race/ethnicity, age, and differentiation
JM Jessup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The potential of proton beam radiation therapy in gastrointestinal cancer
A Ask et al.
ACTA ONCOLOGICA (2005)
Improvement in colorectal cancer survival: A population-based study
E Mitry et al.
EUROPEAN JOURNAL OF CANCER (2005)
Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
J Folkesson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Trends in the management and survival of digestive tract cancers among patients aged over 80 years
AM Bouvier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer:: European Organisation for Research and Treatment of Cancer Gastrointestinal Group study 40986
CH Köhne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
G Folprecht et al.
ANNALS OF ONCOLOGY (2005)
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group
TR Levin et al.
GUT (2005)
Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer:: A Spanish cooperative group for the treatment of digestive tumors study
J Sastre et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
Y Seium et al.
ANNALS OF ONCOLOGY (2005)
Time trends in the treatment and survival of recurrences from colorectal cancer
F Guyot et al.
ANNALS OF ONCOLOGY (2005)
Meta-analysis: Computed tomographic colonography
BP Mulhall et al.
ANNALS OF INTERNAL MEDICINE (2005)
Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial
CAM Marijnen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Never too old?: Age should not be a barrier to enrollment in cancer clinical trials
MS Aapro et al.
ONCOLOGIST (2005)
Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients
G Rosati et al.
ONCOLOGY (2005)
Colonoscopy in the very elderly is safe and worthwhile
WK Syn et al.
AGE AND AGEING (2005)
Outcomes of safe, simple colonoscopy in older adults
F Cardin et al.
AGE AND AGEING (2005)
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer:: a pooled analysis of clinical trials
G Folprecht et al.
ANNALS OF ONCOLOGY (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Are survival rates different for young and older patients with rectal cancer?
JB O'Connell et al.
DISEASES OF THE COLON & RECTUM (2004)
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials
E Mitry et al.
ANNALS OF ONCOLOGY (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial
ML Rothenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial
CAM Marijnen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom
DK Whynes et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2003)
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
W Scheithauer et al.
ANNALS OF ONCOLOGY (2003)
Three-dimensional endoluminal CT colonography (virtual colonoscopy): Comparison of three commercially available systems
PJ Pickhardt
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Colorectal cancer, screening and survival: the influence of socio-economic deprivation
DK Whynes et al.
PUBLIC HEALTH (2003)
Benefit of operative mortality reduction on colorectal cancer survival
E Mitry et al.
BRITISH JOURNAL OF SURGERY (2002)
Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers
CP Delaney et al.
ANNALS OF SURGERY (2002)
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial
JH Scholefield et al.
GUT (2002)
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial
WS Atkin et al.
LANCET (2002)
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer
V Sundararajan et al.
ANNALS OF INTERNAL MEDICINE (2002)
Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial
CAM Marijnen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients
C Poole et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer
AL Potosky et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients
DJ Sargent et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Age and adjuvant chemotherapy use after surgery for stage III colon cancer
D Schrag et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Colonic screening and surveillance
O Kronborg
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2001)
Faecal occult blood testing in the secondary prevention of colorectal cancer
O Kronborg
EUROPEAN JOURNAL OF CANCER PREVENTION (2001)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Surgery for colorectal cancer in elderly patients: a systematic review
P Simmonds et al.
LANCET (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
分享论文
